SavedAdd your journal

Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 1

Agressive Posterior Retinopathy of Prematurity (AP-ROP)

Agresif Posterior Prematüre Retinopatisi (AP-ROP)

Gamze TÜRE
Seda ADIYEKE KARACA
Pages
63–68
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although subjective in nature, plus disease, and any posterior pole changes especially at the border of vascular and avascular retina should be carefully evaluated, keeping AP-ROP in mind in especially high-risk preterm babies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Agressive retinopathy of prematurity (AP-ROP) has subtle clinical findings which may preclude early diagnosis and treatment.
📊
Key Findings & Data:Premature infants with AP-ROP has a progressive clinical course and may benefit from early laser treatment.
💡
Conclusion & Impact:Although subjective in nature, plus disease, and any posterior pole changes especially at the border of vascular and avascular retina should be carefully evaluated, keeping AP-ROP in mind in especially high-risk preterm babies
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Agressive retinopathy of prematurity (AP-ROP) has subtle clinical findings which may preclude early diagnosis and treatment. Premature infants with AP-ROP has a progressive clinical course and may benefit from early laser treatment. Although subjective in nature, plus disease, and any posterior pole changes especially at the border of vascular and avascular retina should be carefully evaluated, keeping AP-ROP in mind in especially high-risk preterm babies

Özet

Agresif posterior prematüre retinopatisinde (AP-ROP) klinik bulgular belirgin olmadığı için tanı ve tedavi gecikebilir. APROP bulunan prematüre bebekler ilerleyici klinik seyir gösterir ve erken lazer tedavisinden fayda görebilir. Yüksek riskli bebeklerde, arka kutupta, özellikle vasküler-avasküler retina sınırında görülen değişiklikler ve subjektif özellik gösterse de plus hastalık, AP-ROP akılda tutularak dikkatle değerlendirilmelidir

🔖

Cite This Article

TÜRE, G., KARACA, S. A. (2018). Agressive Posterior Retinopathy of Prematurity (AP-ROP). Güncel Retina Dergisi, Cilt: 2 - Sayı: 1, 63–68. https://ajindex.com/articles/192620

References (1)

  1. 1 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123(7): 991-9. 2 Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity randomized trial. Trans Am Ophthalmol Soc 2004; 102: 233–248. 3 Yokoi T, Hiraoka M, Miyamoto M, et al. Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 2009; 116(7): 1377-82. 4 Schulenburg WE, Tsanaktsidis G. Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants. Br J Ophthalmol 2004; 88(12): 1500-3. 5 Ahn SJ, Kim JH, Kim SJ, Yu YS. Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation. Korean J Ophthalmol. 2013; 27(2): 109-15. 6 Lorenz B, Stieger K, Jäger M, Mais C, Stieger S, Andrassi-Darida M. Retinal vascular development with 0.312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: A longitudinal Fluorescein Angiographic Study. Retina. 2017; 37(1): 97-11. 7 Vinekar A, Chidambara L, Jayadev C, Sivakumar M, Webers CA, Shetty B. Monitoring neovascularization in aggressive posterior retinopathy of prematurity using optical coherence tomography angiography. J AAPOS 2016; 20(3): 271-4. 8 Quinn GE, Ying GS, Daniel E, et al. e-ROP Cooperative Group. Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA Ophthalmol. 2014;132(10):1178–84. 9 Yonekawa Y, Thomas BJ, Thanos A, Todorich B, Drenser KA, Trese MT, Capone A Jr. The cutting edge of retinopathy of prematurity care: Expanding the Boundaries of Diagnosis and Treatment. Retina. 2017; 37(12): 2208-2225. 10 Sims KB. NDP-Related Retinopathies. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N (eds) In: GeneReviews®[Internet]. Seattle (WA):University of Washington, Seattle 1999; 1993-2017. 11 Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1988; 106(4): 471–9. 12 Cuthbertson F, Newsom R. UK retinopathy of prematurity treatment survey. Eye 2007; 21(12): 156-7. 13 Parvaresh MM, Ghasemi Falavarjani K, Modarres M, Nazari H, Saiepour N. Transscleral d